Two Phase 3 Trials of Inclisiran in Patients with Elevated LDL Cholesterol. [electronic resource]
Producer: 20200427Description: 1507-1519 p. digitalISSN:- 1533-4406
- Aged
- Aged, 80 and over
- Anticholesteremic Agents -- adverse effects
- Cardiovascular Diseases
- Cholesterol, LDL -- blood
- Coronary Artery Disease -- complications
- Double-Blind Method
- Drug Administration Schedule
- Female
- Humans
- Hydroxymethylglutaryl-CoA Reductase Inhibitors -- therapeutic use
- Hypercholesterolemia -- blood
- Injections, Subcutaneous -- adverse effects
- Liver Function Tests
- Male
- Middle Aged
- PCSK9 Inhibitors
- RNA, Small Interfering -- adverse effects
- Risk Factors
No physical items for this record
Publication Type: Clinical Trial, Phase III; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.